Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Belcher

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|November 2, 2024
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literaturePaul E Belcher, Anna Moberg, Michael B Murphy
Bioconjugate Chemistry|July 20, 2011
Engineering a synthetic ligand for tumor necrosis factor-alphaNidhi Gupta, Paul E Belcher, Stephen Albert Johnston, et al.
Analytical Biochemistry|March 10, 2010
High-throughput screening in two dimensions: binding intensity and off-rate on a peptide microarrayMatthew P Greving, Paul E Belcher, Conor D Cox, et al.
Plos One|May 27, 2010
Discovery of high-affinity protein binding ligands--backwardsChris W Diehnelt, Miti Shah, Nidhi Gupta, et al.
Analytical Chemistry|June 23, 2017
Cross-Reactive Synbody Affinity Ligands for Capturing Diverse NorovirusesNidhi Gupta, John C Lainson, Paul E Belcher, et al.
Plos One|November 19, 2010
Thermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural informationMatthew P Greving, Paul E Belcher, Chris W Diehnelt, et al.
Journal of Natural Products|May 5, 2011
Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline unitsGeorge R Pettit, Thomas H Smith, Jun-Ping Xu, et al.
Journal of Natural Products|February 18, 2015
Antineoplastic agents. 599. Total synthesis of dolastatin 16George R Pettit, Thomas H Smith, Pablo M Arce, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
SLAS Discovery : Advancing Life Sciences R & D|November 2, 2024
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literaturePaul E Belcher, Anna Moberg, Michael B Murphy
Bioconjugate Chemistry|July 20, 2011
Engineering a synthetic ligand for tumor necrosis factor-alphaNidhi Gupta, Paul E Belcher, Stephen Albert Johnston, et al.
Analytical Biochemistry|March 10, 2010
High-throughput screening in two dimensions: binding intensity and off-rate on a peptide microarrayMatthew P Greving, Paul E Belcher, Conor D Cox, et al.
Plos One|May 27, 2010
Discovery of high-affinity protein binding ligands--backwardsChris W Diehnelt, Miti Shah, Nidhi Gupta, et al.
Analytical Chemistry|June 23, 2017
Cross-Reactive Synbody Affinity Ligands for Capturing Diverse NorovirusesNidhi Gupta, John C Lainson, Paul E Belcher, et al.
Plos One|November 19, 2010
Thermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural informationMatthew P Greving, Paul E Belcher, Chris W Diehnelt, et al.
Journal of Natural Products|May 5, 2011
Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline unitsGeorge R Pettit, Thomas H Smith, Jun-Ping Xu, et al.
Journal of Natural Products|February 18, 2015
Antineoplastic agents. 599. Total synthesis of dolastatin 16George R Pettit, Thomas H Smith, Pablo M Arce, et al.
Pageof 1